A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH

Clinical trial NCT03818607 · COMPLETED

Trial details

NCT number: NCT03818607
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2019-01-22
Primary completion: 2022-07-12
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.